# Improve Management of Heart Failure With Procalcitonin

> **NCT02392689** · NA · TERMINATED · sponsor: **Brahms AG** · enrollment: 759 (actual)

## Conditions studied

- Heart Failure
- Infection

## Interventions

- **OTHER:** Procalcitonin

## Key facts

- **NCT ID:** NCT02392689
- **Lead sponsor:** Brahms AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2018-04-05
- **Final completion:** 2018-04-14
- **Target enrollment:** 759 (ACTUAL)
- **Why stopped:** At 75% patient completion overall mortality was much lower than expected and without significant difference at day 90. No chance to reach the primary endpoint.
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02392689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02392689, "Improve Management of Heart Failure With Procalcitonin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02392689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*